BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15910493)

  • 1. Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study.
    Cacciola I; Spatari G; Pollicino T; Costantino L; Zimbaro G; Brancatelli S; Fenga C; Caccamo G; Squadrito G; Raimondo G
    Liver Int; 2005 Jun; 25(3):555-63. PubMed ID: 15910493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.
    Kao JH; Chen PJ; Lai MY; Chen DS
    J Med Virol; 2004 Mar; 72(3):363-9. PubMed ID: 14748059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients.
    Raimondo G; Brunetto MR; Pontisso P; Smedile A; Maina AM; Saitta C; Squadrito G; Tono N;
    Hepatology; 2006 Jan; 43(1):100-7. PubMed ID: 16323213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.
    Chu CM; Chen YC; Tai DI; Liaw YF
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):535-40. PubMed ID: 20304099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.
    Brunetto MR; Oliveri F; Colombatto P; Moriconi F; Ciccorossi P; Coco B; Romagnoli V; Cherubini B; Moscato G; Maina AM; Cavallone D; Bonino F
    Gastroenterology; 2010 Aug; 139(2):483-90. PubMed ID: 20451520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinatal and intrafamily transmission of hepatitis B virus in three generations of a low-prevalence population.
    Ordög K; Szendrôi A; Szarka K; Kugler Z; Csire M; Kapusinszky B; Xie J; Csizmadia K; Brojnás J; Rusvai E; Tempfli A; Berencsi G
    J Med Virol; 2003 Jun; 70(2):194-204. PubMed ID: 12696105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
    Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
    J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors.
    Allain JP; Sarkodie F; Candotti D; Opare-Sem O
    Transfusion; 2005 Jun; 45(6):1039-40. PubMed ID: 15935007
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
    J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers.
    Datta S; Banerjee A; Chandra PK; Chowdhury A; Chakravarty R
    J Med Virol; 2006 Jan; 78(1):53-9. PubMed ID: 16299727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of HbsAg and HBV DNA in serum and saliva of HBV carriers.
    Noppornpanth S; Sathirapongsasuti N; Chongsrisawat V; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):419-21. PubMed ID: 11127351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.
    Niitsuma H; Ishii M; Miura M; Kobayashi K; Toyota T
    Am J Gastroenterol; 1997 Jan; 92(1):119-23. PubMed ID: 8995950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours.
    Alexopoulos CG; Vaslamatzis M; Hatzidimitriou G
    Br J Cancer; 1999 Sep; 81(1):69-74. PubMed ID: 10487614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of specific IgA and IgM anti-HBc antibodies compared with HBV DNA in the sera of HBsAg chronic carriers.
    Elsana S; Shemer-Avni Y; Sikuler E; Sarov B; Naggan L; Bar-Shany S; Gilon E; Yaari A; Orgel M; Frazer GM; Margalith M
    J Hum Virol; 1997; 1(1):52-7. PubMed ID: 10195231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of genotypes C and D of the hepatitis B virus in Japan: a clinical and molecular biological study.
    Duong TN; Horiike N; Michitaka K; Yan C; Mizokami M; Tanaka Y; Jyoko K; Yamamoto K; Miyaoka H; Yamashita Y; Ohno N; Onji M
    J Med Virol; 2004 Apr; 72(4):551-7. PubMed ID: 14981757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus superinfection in hepatitis B virus chronic carriers: a reciprocal viral interaction and a variable clinical course.
    Sagnelli E; Coppola N; Marrocco C; Onofrio M; Sagnelli C; Coviello G; Scolastico C; Filippini P
    J Clin Virol; 2006 Mar; 35(3):317-20. PubMed ID: 16316779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
    Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
    Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers.
    Colson P; Borentain P; Motte A; Henry M; Moal V; Botta-Fridlund D; Tamalet C; Gérolami R
    Virology; 2007 Oct; 367(1):30-40. PubMed ID: 17573090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.